Intravenous application of high doses of antilymphocytic globulin (ALG) was successful in the suppression of severe rejection crisis in heart and kidney transplantation , 1970 . Encouraged by this favourable experience we decided to treat autoimmune diseases with ALG. Autoimmune processes in neurological as well as in other diseases are thought to be initiated by exogenous factors such as slow virus infections, or by endogenous factors, for example a genetic defect of the immune system. When nervous tissue becomes an autoantigen, immune competent cells are sensitized and later produce humoral antibodies and/or killer cells against the body's own nervous tissue. Alternatively, it might be possible that, during development of an organism, a clone of lymphocytes is not eliminated, although it contains antibodies against the body's nervous tissue. Nervous tissue would then be attacked by these cells and destroyed, and consequently autoantigenic material released, initiating a process of self-perpetuation. According to this hypothesis all procedures which influence or interrupt this kind of autoimmune reaction should have a therapeutic effect. Some arguments for autoimmunization in neurological diseases are shown in Tables 1 and 2. Experimental allergic encephalomyelitisa model of multiple sclerosisand experimental allergic neuritis are classical examples of autoimmunity (Waksman & Adams 1955 , 1962 . Similar findings can be observed in human beings with diseases such as sympathetic ophthalmia (Lemoine & Verhoeff 1922 , Uhlenhuth 1903 , Witebsky & Milgrom 1964 , Woods 1961 ) and sometimes after rabies vaccination (Jellinger & Seitelberger 1958 , Shiraki & Otani 1959 , Uchimura & Shiraki 1957 . In multiple sclerosis and encephalomyelitis diffusa only a few investigators have found lymphocytes sensitized against nervous tissue (Berg & Kaellen 1964) , but nevertheless clinical data like successful immunosuppression (Brendel , 1971 , at least in some cases, favour the theory of the immunological character of these diseases. More arguments for an autoimmune process can be obtained if the humoral factors are considered (Table 2) . High values of immunoglobulins can be observed in most of the diseases mentioned, and there may be complement-fixing and eventually precipitating or cytotoxic antibodies against brain tissue. All these findings, though partially contested, indicate that immunological processes are involved and Bunina 1962 , Sagre 1957 Experimental allergic neuropathy + (Waksman & Adams 1955 , 1956 Myasthenia gravis (Brendel et al. 1970 , Brendel 1971 , Simpson 1960 that immune suppressive therapy might therefore be justified. A further argument for the immune suppressive therapy was the successful treatment of animals suffering from experimental allergic encephalomyelitis with ALG .
A schedule of treatment called maximum immune suppression (Brendel 1971) (Fig 1) , and aimed at getting a decrease of immune competent lymphocytes and humoral antibodies, was developed. It consists of drainage of the thoracic duct followed by administration of ALG, azathioprine and steroids and is continued for as long as remission of clinical symptoms is observed. Our purpose in giving steroids and azathioprine is to increase the immune suppressive effect of horse ALG and to reduce the reaction of the patient to the administered horse protein. For the same reasons an attempt was made to induce immunological tolerance against horse gammaglobulin by injecting ultracentrifuged highly purified horse gamma-globulin G in a dose of 10 mg/kg body weight 6 days and 30 mg/kg body weight 3 days before ALG administration. With this method, unresponsiveness to horse gammaglobulin was achieved in 90%. It was tested with passive hxmagglutination and with the antigen elimination technique. The ALG was produced from cultured lymphoblasts. All batches of ALG, especially the IgG fractions, were free from antibodies against the glomerular basement membrane. All the ALG had an immune suppressive effect proved by skin tests in chimpanzees and monkeys, which were carried out by Dr H Balner in Rijswik, Holland. Patients tolerated ALG therapy without serious reactions.
Thirty-seven cases were treated: 14 autoimmune diseases without neurological symptoms (i.e. lupus erythematosus, dermatomyositis, temporal arteritis), and 23 neurological diseases (multiple sclerosis 17, encephalomyelitis diffusa 2, motor neurone disease 1, sympathetic ophthalmia 2, myasthenia gravis 1). Only in 9 neurological cases was it possible to perform the whole pattern of maximum suppression with thoracic duct drainage, steroids and azathioprine (Table  3) . One patient received ALG alone, 5 patients were treated with ALG and steroids and 5 with ALG, steroids and azathioprine. Three of our patients were sensitized against horse protein and consequently ALG could not be given. Nevertheless, variations in our schedule of therapy allowed effective immunosuppressive treatment with other drugs.
Our neurological colleagues, Professor E Frick and Dr H Backmund, selected patients whose disease was rapidly getting worse in spite of treatment with azathioprine, steroids or other drugs. Some showed continuous and others intermittent deterioration. Fig 2 demonstrates a case of VI-point severity according to the Bronx scale (Kurtzke 1965) . In seven months the 25year-old patient developed symptoms of multiple sclerosis intermittently; he had spastic paralysis in all extremities, double vision, bladder and intestinal dysfunctions and different sensitivity disorders. Most of these symptoms and in particular the spastic paralysis disappeared after treatment with maximum immune suppression, and the patient remained in this good state for two years. He has just a slight sensitivity disturbance in the right cheek. Fig 3 shows was not possible to administer ALG because the patient was presensitized against horse and even rabbit protein.
Another very fascinating result was in a patient suffering from motor neurone disease with typical muscle fasciculations, a dangerous reduction in vital capacity and some bulbar disorders. It was decided to treat him with maximum immunosuppression although it can be doubted whether motor neurone disease is due to an immunological process. The vital capacity changed to normal andeven more importantthe muscle fasciculation diminished considerably, the latter being recorded electromyographically by Professor 0 Creutzfeld from the Max Planck Institute of Psychiatry, Munich. The only explanation for this effect is the hypothesis that in this patient the degenerative disorders in the anterior horn cells were not definitive and the inflammatoryprocesses were still dominant.
A summary of the results is shown in Table 4 . We surveyed Cases 1-13, having symptoms of severe deterioration lasting 6 months, for more than a year. The results of treatment depended on the continuous or intermittent course of the disease. In continuous cases we could only slow the progress of the disease, we could not cause improvement. But even this result is considered a success if lasting longer than two years. In cases with intermittent course we observed variable improvement as shown by points on the Bronx scale. It is noticeable that it is possible to elimate especially spastic paralysis, which means a lot to the patient who can then walk again and look after himself, but it was not possible to improve flaccid paralysis. A case of myasthenia gravis was less convincing: however, the patient is now on a reduced dosage of pyridostigmine. Two boys, aged 13 and 16, who were practically blind with sympathetic ophthalmia, recovered during two months' treatment; for two years now they have been able to read and follow lessons in school.
The latest cases (Table 4 , Cases 14-23), treated during the last year, show similar results. In these cases patients with a longer history were selected. Clinical improvement according to the Bronx scale was less convincing than in earlier cases with a history of six months. One patient with chronic multiple sclerosis died shortly after arrival in our hospital due to bleeding from a stomach ulcer. At autopsy we found many ulcers in the stomach, probably due to prolonged Table 4 Results in patients observed for longer than twelve months (Cases 1-13) and for less than twelve months (Cases 14-23) Section ofNeutrology 535 previous treatment with high doses of steroids. Furthermore, the treatment failed in a patient with encephalomyelitis diffusa. She had a severe hypersensitivity to horse protein with a spontaneous titre above 1:1,000 in passive hamagglutination, which had never been observed before. It must be admitted that this therapy is not free of risks and complication. Apart from the fatal outcome of the two cases just mentioned, the following complications must be taken into account. The drainage of the thoracic duct was not possible in two cases because there were too many anastomoses of the duct before it entered the vena. Once a lesion of the recurrent laryngeal nerve was observed and three times a lymph fistula occurred because the thoracic duct failed to close properly after removal of the catheter. The application of horse globulin was not possible in 3 cases and 1 case of anaphylactic hypotension after ALG treatment was easily controlled by vasoconstrictive drugs. Transient urticaria and shivering was observed twice and a serum nephritis once. We have seen no sign of tumour growth in cases of autoimmune disease or in 200 kidney transplantations treated with high doses of ALG in the last three years.
Finally, attention must be drawn to a more theoretical interpretation. At present there are not enough arguments favouring the hypothesis that immunological processes play an important role in the diseases just mentioned. But if clinical improvement can be achieved by maximum immune suppression it may be concluded retrospectively that autoaggression is involved in these diseases.
Summarizing the results, it can be said that the fulminant course of these diseases can be slowed in most cases, if the course is continuous. If the course is intermittent, the development of the diseases can not only be slowed but also significant remission of various neurological disorders can be achieved. This was the case in 15 of 23 patients. Of course, it is impossible to restore destroyed nervous tissue, but it might be possible to prevent nervous tissue damage by starting a strong and combined immune suppressive therapy earlier than it has been done so far. Severe cases were selected only in order to be sure the observed improvement was due to our therapy and not to spontaneous remissions. Therefore, only those patients with fulminant disease and in whom therapy with steroids and azathioprine had been ineffective were treated. The turning point in the fate of these patients was produced by ALG administration and/or the drainage of the thoracic duct. Since most of these diseases have a lethal outcome, maximum immune suppression seems to offer a real hope of improvement.
